IL6 and COVID-19: Similarly, serum IL-6, CXCL8, TNFα levels were increased in hospitalized COVID-19 patients (n = 1484) compared to non-infected by SARS-CoV-2 (n = 257) and serum levels of these pro-inflammatory mediators were positively correlated with mortality [186].